Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Helping people living with serious diseases and their families is the guiding principle at the heart of Barinthus Biotherapeutics. With a broad pipeline, built around four proprietary platform technologies: ChAdOx, MVA, SNAP-TI, and SNAP-CI; Barinthus Biotherapeutics is advancing a pipeline of five product candidates across a diverse range of therapeutic areas, including: VTP-300, an immunotherapeutic candidate designed as a potential component of a functional cure for chronic HBV infection; VTP-1000, an autoimmune candidate designed to utilize the SNAP-TI platform to treat patients with celiac disease; and VTP-850, a second-generation immunotherapeutic candidate designed to treat recurrent prostate cancer. Barinthus Biotherapeutics’ proven scientific expertise, diverse portfolio and focus on pipeline development uniquely positions the company to navigate towards delivering treatments for people with infectious diseases, autoimmunity and cancers that have a significant impact on their everyday lives.
Company Details
- Employees
- 77
- Founded
- -
- Address
- Units 6-10 Zeus Building, Rutherford Avenue, Harwell,oxfordshire Ox11 0df,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Research, Immunotherapy, Infectious Disease, Oncology, Viral vectors, HBV, HPV, Prostate cancer, Non-small cell lung cancer, Hepatitis B, Celiac, SNAP, nanoparticles.
- HQ
- Harwell, Oxfordshire
Barinthus Biotherapeutics Questions
Barinthus Biotherapeutics's website is http://+https://www.barinthusbio.com
Barinthus Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/barinthusbiotherapeutics
Barinthus Biotherapeutics has
77 employees.
View email and phone details for 77
employees at Barinthus Biotherapeutics.
Barinthus Biotherapeutics's industry is
Biotechnology Research
Barinthus Biotherapeutics's top competitors are
Vertex Pharmaceuticals,
Exscientia,
Immunocore,
Adaptimmune,
Akamis Bio,
Moderna,
Evox Therapeutics Ltd,
Enara Bio,
Oxb,
Theolytics.
Barinthus Biotherapeutics's categories are Biotechnology Research
Barinthus Biotherapeutics's founding year is 2016
